Specific features of the diagnosis and treatment of community-acquired pneumonia in pregnant women


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The diagnosis of community-acquired pneumonia and the choice of adequate therapy during pregnancy have a number of features. This is due to both clinical features and certain restrictions on the prescription of antibacterial drugs, some groups of which may have a negative effect on a fetus.

Full Text

Restricted Access

About the authors

O. Lavrova

I.P. Pavlov First Saint Petersburg State Medical University

Email: loverova@bk.ru
Professor MD

M. Petrova

I.P. Pavlov First Saint Petersburg State Medical University

Professor MD

References

  1. Чучалин А.Г. и соавт. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике // Клин. микробиол. антимикроб. химиотер. - 2006; 8 (1): 54-86.
  2. Внебольничная пневмония. Клинические рекомендации / Российское респираторное общество, 2018. spulmo.ru
  3. Jin Y., Carriere K., Marrie T. et al. The effects of community-acquired pneumonia during pregnancy ending in a live birth // Am. J. Obstet. Gynecol. -2003; 18: 800-6.
  4. Goodnight W., Soper D. Pneumonia in pregnancy // Crit. Care Med. - 2005; 33 (10 Suppl) : 390-7.
  5. Panting-Kemp A., Geller S., Nguyen T. et al. Maternal deaths in an urban perinatal network, 1992-1998 // Am. J. Obstet. Gynecol. - 2000; 183: 1207-12.
  6. Lim W., Macfarlane J., Colthorpe C. Treatmentof community-acquired lower respiratory tract infections during pregnancy // Am. J. Respir. Med. - 2003; 2: 221-33.
  7. Mehta N., Chen K., Hardy E. et al. Pneumonia in pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. - 2015; 29 (5): 598-611.
  8. Madinger N., Greenspoon J., Ellrodt A. Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome? // Am. J. Obstet. Gynecol. - 1989; 161: 657-62.
  9. Синопальников А.И., Фесенко О.В. Внебольничная пневмония / М.: ГЭОТАР-Медиа, 2017; 112 с.
  10. Tan E.K., Tan E.L. Alterations in physiology and anatomy during pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. - 2013; 27: 791-802.
  11. Brito V., Niederman M. Pneumonia complicating pregnancy // Clin. Chest Med. - 2011; 32: 121-32.
  12. Romanyuk V., Raichel L., Sergienko R. et al. Pneumonia during pregnancy: radiological characteristics, predisposing factors and pregnancy outcomes // J. Matern. Fetal. Neonatal. Med. - 2011; 24 (1): 113-7.
  13. Ie S., Rubio E., Alper B. et al. Respiratory complications of pregnancy // Obstet. Gynecol. Surv. - 2001; 57: 39-46.
  14. Wacker E., Navarro A., Meister R. et al. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome // Pharmacoepidemiol. Drug Saf. - 2015; 24 (4): 353-60.
  15. Berkovitch M., Diav-Citrin O., Greenberg R. et al. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study // Br. J. Clin. Pharmacol. - 2004; 58 (3): 298-302.
  16. Czeizel A., Rockenbauer M., Sorensen H. et al. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study // Eur. J. Obstet. Gynecol. Reprod. Biol. - 2001; 97 (2): 188-92.
  17. Lin K., Mitchell A., Yau W. et al. Safety of macrolides during pregnancy // Am. J. Obstet. Gynecol. - 2013; 208 (3): 221.e1-8. DOI: 10.1016/j. ajog.2012.12.023.
  18. Padberg S., Wacker E., Meister R. et al. Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones // Antimicrob. Agents Chemother. - 2014; 58 (8): 4392-8. doi: 10.1128/AAC.02413-14.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies